NasdaqGS - Delayed Quote USD
Inogen, Inc. (INGN)
At close: 4:00 PM EDT
After hours: 4:03 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
326,653.00
315,660.00
377,241.00
358,003.00
308,487.00
Cost of Revenue
187,623.00
188,961.00
223,708.00
181,520.00
170,307.00
Gross Profit
139,030.00
126,699.00
153,533.00
176,483.00
138,180.00
Operating Expense
205,177.00
203,191.00
186,615.00
167,243.00
150,205.00
Operating Income
-66,147.00
-76,492.00
-33,082.00
9,240.00
-12,025.00
Net Non Operating Interest Income Expense
6,139.00
6,574.00
2,837.00
129.00
909.00
Other Income Expense
-32,723.00
-32,426.00
-53,023.00
-710.00
5,836.00
Pretax Income
-92,731.00
-102,344.00
-83,268.00
8,659.00
-5,280.00
Tax Provision
-289.00
105.00
504.00
14,992.00
549.00
Net Income Common Stockholders
-92,442.00
-102,449.00
-83,772.00
-6,333.00
-5,829.00
Diluted NI Available to Com Stockholders
-92,442.00
-102,449.00
-83,772.00
-6,333.00
-5,829.00
Basic EPS
-3.97
-4.42
-3.67
-0.28
-0.27
Diluted EPS
-3.97
-4.42
-3.67
-0.28
-0.27
Basic Average Shares
23,391.12
23,176.10
22,852.57
22,490.03
21,980.33
Diluted Average Shares
23,391.12
23,176.10
22,852.57
22,490.03
21,980.33
Total Operating Income as Reported
-99,041.00
-109,386.00
-85,243.00
9,240.00
-12,025.00
Rent Expense Supplemental
31,424.00
30,325.00
25,903.00
19,696.00
13,543.00
Total Expenses
392,800.00
392,152.00
410,323.00
348,763.00
320,512.00
Net Income from Continuing & Discontinued Operation
-92,442.00
-102,449.00
-83,772.00
-6,333.00
-5,829.00
Normalized Income
-59,650.52
-76,462.74
-42,564.81
-6,333.00
-5,829.00
Interest Income
6,139.00
6,574.00
2,837.00
129.00
909.00
Net Interest Income
6,139.00
6,574.00
2,837.00
129.00
909.00
EBIT
-66,147.00
-76,492.00
-33,082.00
9,240.00
-12,025.00
EBITDA
-45,779.00
-58,340.00
-9,568.00
30,868.00
6,556.00
Reconciled Cost of Revenue
187,623.00
188,961.00
223,708.00
181,520.00
170,307.00
Reconciled Depreciation
20,368.00
18,152.00
23,514.00
21,628.00
18,581.00
Net Income from Continuing Operation Net Minority Interest
-92,442.00
-102,449.00
-83,772.00
-6,333.00
-5,829.00
Total Unusual Items Excluding Goodwill
-32,894.00
-32,894.00
-52,161.00
--
--
Total Unusual Items
-32,894.00
-32,894.00
-52,161.00
--
--
Normalized EBITDA
-12,885.00
-25,446.00
42,593.00
30,868.00
6,556.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-102.52
-6,907.74
-10,953.81
--
--
12/31/2020 - 2/14/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ZIMV ZimVie Inc.
14.86
-0.60%
SGHT Sight Sciences, Inc.
6.02
+3.61%
AXGN Axogen, Inc.
14.46
+0.77%
FNA Paragon 28, Inc.
5.83
+1.57%
NVRO Nevro Corp.
5.08
-1.17%
CVRX CVRx, Inc.
8.36
+4.24%
STE STERIS plc
225.99
-0.31%
KIDS OrthoPediatrics Corp.
27.75
+2.66%
CLPT ClearPoint Neuro, Inc.
11.98
-0.50%
AXDX Accelerate Diagnostics, Inc.
1.9000
+1.60%